GLPwatch

Anti-stress effects of the glucagon-like peptide-1 receptor agonist liraglutide in zebrafish.

Prog Neuropsychopharmacol Biol Psychiatry · 2021

Last updated 2026-05-28

In a study on zebrafish, the GLP-1 drug liraglutide reduced anxiety-like behaviors after a single dose and prevented stress-related changes in behavior and brain chemistry when given over time. The research suggests liraglutide may have effects on the brain that could help counteract stress, but more studies are needed to understand its potential for treating brain disorders.

AI summary of the abstract below.

JournalProg Neuropsychopharmacol Biol Psychiatry, 2021
Citations14
Relative citation ratio1.29
NIH percentile59
Molecules liraglutide

Abstract

Stress-related disorders are extremely harmful and cause significant impacts on the individual and society. Despite the limited evidence regarding glucagon-like peptide-1 receptor (GLP-1R) and mental disorders, a few clinical and preclinical studies suggest that modulating this system could improve symptoms of stress-related disorders. This study aimed to investigate the effects of liraglutide, a GLP-1R agonist, on neurobehavioral phenotypes and brain oxidative status in adult zebrafish. Acute liraglutide promoted anxiolytic-like effects in the light/dark test, while chronic treatment blocked the impact of unpredictable chronic stress on behavioral and physiological parameters. Taken together, our study demonstrates that liraglutide is active on the zebrafish brain and may counteract some of the effects induced by stress. More studies are warranted to further elucidate the potential of GLP-1R agonists for the management of brain disorders.

Verbatim abstract via PubMed 34147534 ↗

Related research